Literature DB >> 737905

Circulating immune complexes in active Behçet's disease.

R C Gupta, J D O'Duffy, F C McDuffie, M Meurer, R E Jordon.   

Abstract

Levels of immune complexes (IC) were determined by the Raji-cell and C1q-binding radioimmunoassays in the sera of eighteen patients with Behçet's disease. Eight patients (44%) were found to have significantly elevated levels of IC (range 56 to 1600 microgram equivalent aliquots of heat aggregated IgG (AHG/ml) by the former test and nine by the latter (7 to 500 microgram equivalent AHG/ml). The presence of IC showed a significant correlation with disease activity score (P = 0.003, Mann-Whitney Rank Sum Test). Abnormal values of IC tended to remain abnormal when sera were retested after 1 year. There was no correlation between IC and duration of disease or any specific organ involvement. The IC were found predominantly in fractions of about 19S and greater when fractionated by sucrose density gradient or Sephadex column techniques. The results suggest the possibility that IC may contribute to the pathophysiology of Behçet's disease.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 737905      PMCID: PMC1537490     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  12 in total

1.  Clinical Studies on Behçet's Syndrome.

Authors:  Y Oshima; T Shimizu; R Yokohari; T Matsumoto; K Kano; T Kagami; H Nagaya
Journal:  Ann Rheum Dis       Date:  1963-01       Impact factor: 19.103

2.  C1q binding substances in pemphigus and bullous pemphigoid. Detection with a [131I] C1q binding assay.

Authors:  G Tappeiner; K G Heine; J C Kahl; R E Jordon
Journal:  Clin Exp Immunol       Date:  1977-04       Impact factor: 4.330

3.  Reduction of complement in Behçet's disease and drug allergy.

Authors:  K Shimada; M Kogure; T Kawashima; K Nishioka
Journal:  Med Biol       Date:  1974-08

4.  Studies on circulating immune complexes. 3. Factors governing the ability of circulating complexes to localize in blood vessels.

Authors:  C G Cochrane; D Hawkins
Journal:  J Exp Med       Date:  1968-01-01       Impact factor: 14.307

5.  Autologous-plasma sensitisation in Behcet's disease.

Authors:  D Cooper; R Penny; P Fiddes
Journal:  Lancet       Date:  1971-05-01       Impact factor: 79.321

6.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

7.  Behçet's disease. Report of 10 cases, 3 with new manifestations.

Authors:  J D O'Duffy; J A Carney; S Deodhar
Journal:  Ann Intern Med       Date:  1971-10       Impact factor: 25.391

8.  Binding of soluble immune complexes to Raji lymphocytes. Role of receptors for complement components, C1q and C3-C3b.

Authors:  R C Gupta; F C McDuffie; G Tappeiner; R E Jordon
Journal:  Immunology       Date:  1978-04       Impact factor: 7.397

9.  Immune complexes in Behçet's syndrome and recurrent oral ulceration.

Authors:  B D Williams; T Lehner
Journal:  Br Med J       Date:  1977-05-28

10.  Circulating immune complexes in the serum in systemic lupus erythematosus and in carriers of hepatitis B antigen. Quantitation by binding to radiolabeled C1q.

Authors:  U E Nydegger; P H Lambert; H Gerber; P A Miescher
Journal:  J Clin Invest       Date:  1974-08       Impact factor: 14.808

View more
  17 in total

1.  Cryoglobulins in Behçet's syndrome and recurrent oral ulceration: assay by laser nephelometry.

Authors:  T Lehner; A Losito; D G Williams
Journal:  Clin Exp Immunol       Date:  1979-12       Impact factor: 4.330

2.  Immunohistology of oral lesions from patients with recurrent oral ulcers and Behçet's syndrome.

Authors:  L W Poulter; T Lehner
Journal:  Clin Exp Immunol       Date:  1989-11       Impact factor: 4.330

3.  Natural killer cells in Behçet's disease.

Authors:  K Hamzaoui; K Ayed; M Hamza; J L Touraine
Journal:  Clin Exp Immunol       Date:  1988-01       Impact factor: 4.330

4.  Evaluation of T cell subsets in Behçet's syndrome using anti-T cell monoclonal antibodies.

Authors:  G Valesini; P Pivetti-Pezzi; F Mastrandrea; A Moncada; M Cuomo; P G Natali
Journal:  Clin Exp Immunol       Date:  1985-04       Impact factor: 4.330

Review 5.  Immune complexes in human diseases: a review.

Authors:  A N Theofilopoulos; F J Dixon
Journal:  Am J Pathol       Date:  1980-08       Impact factor: 4.307

6.  The Presence of Autoantibodies Against Vascular and Nervous Tissue in Sera From Patients with Neuro-Behçet's Disease.

Authors:  Ayşe İlksen Colpak; Umut Kalyoncu; Yasemin Gürsoy Özdemir
Journal:  Noro Psikiyatr Ars       Date:  2014-06-01       Impact factor: 1.339

7.  The proteins of the aqueous humour.

Authors:  J P Dernouchamps
Journal:  Doc Ophthalmol       Date:  1982-11-01       Impact factor: 2.379

8.  Kidney involvement in Behçet's syndrome. A report of 11 cases studied by optic, ultrastructural and immunopathological techniques.

Authors:  H Beaufils; B Cassou; M Auriol; G Herreman; B Wechsler; J C Roujeau; P Godeau; G Chomette
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1980

9.  Circulating immune complexes in Behçet's syndrome: purification, characterization and cross-reactivity studies.

Authors:  G Valesini; M Picardo; R Pastore; P Pivetti; U Serafini
Journal:  Clin Exp Immunol       Date:  1981-06       Impact factor: 4.330

10.  Transient neonatal Behcet's disease.

Authors:  M A Lewis; B L Priestley
Journal:  Arch Dis Child       Date:  1986-08       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.